Showing results (11-20 of 14) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Multiple Sclerosis and Related Disorders|June 15, 2026
Real world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosisP C G Molenaar, D L Weir, E P J Arnoldus, et al.Journal of Neurology|July 23, 2025
Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS)W H Fung, M H J Wessels, E M E Coerver, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 4, 2024
Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patientsAlyssa A Toorop, Mark Hj Wessels, Lynn Boonkamp, et al.Journal of the Neurological Sciences|June 26, 2024
Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trialA A Toorop, M H J Wessels, L M Y Gelissen, et al.Pageof 2